Skip to main content
. 2023 May 22;23:468. doi: 10.1186/s12885-023-10957-5

Table 1.

Clinico-radiological and pathological features of the patients with BCBM

Variable No. Percent
Age (year) < 60 35 70%
≥ 60 15 30%
Sex Female 49 98%
Male 1 2%
Molecular type Luminal A 10 20%
Luminal B 6 12%
HER2 19 38%
TN 15 30%
CAF pattern Type A 24 48%
Type B 20 40%
Type C 6 12%
PDGFR-β Low 27 54%
High 23 46%
α-SMA Low 27 54%
High 23 46%
Tumor location Supratentorial 37 74%
Infratentorial 13 26%
Extracranial Mets Absent 12 24%
Present 38 76%
BM symptom Mild to moderate 31 62%
Severe 19 38%
KPS ≥ 80 32 64%
< 80 18 36%
BM multiplicity Single 24 48%
Multiple 26 52%
BM development Metachronous 49 98%
Synchronous 1 2%
BM size < 4 cm 22 44%
≥ 4 cm 28 56%
Peritumoral edema Mild to moderate 27 54%
Severe 23 46%
Tumor nature Solid 27 54%
Cystic or mixed 23 46%
Resection degree Gross total 38 76%
Partial to subtotal 12 24%
Postoperative RT/GKS Absent 16 32%
Present 34 68%

BC, breast cancer; BM, brain metastasis; α-SMA, alpha-smooth muscle actin; CAF, cancer-associated fibroblast; GKS, gamma knife radiosurgery; KPS, Karnofsky performance score; Mets, metastasis; PDGFR-β, platelet-derived growth factor receptor-beta; RT, radiation treatment; TN, triple negative